Apeiron Investment Group Ltd. bought ANRO
February 6, 2024 · Form 4 insider transaction
Apeiron Investment Group Ltd. bought 251,881 shares of Alto Neuroscience, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 29 days after the transaction.
Direction
Acquired (buy-side)
Shares
251,881
Price
N/A
Total value
N/A
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateFebruary 6, 2024
Filing dateMarch 6, 2024
Shares owned after251,881
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis.; The reportable securities are held by Apeiron Investment Group Ltd. ("Apeiron"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities.